Figure 4. Levels of plasma globotriaosylceramide (Gb3 ) in male hemizygotes with classic Fabry disease and with the N215S mutation, in female heterozygotes and in healthy control individuals.

Figure 4

Levels of plasma globotriaosylceramide (Gb3 ) in male hemizygotes with classic Fabry disease and with the N215S mutation, in female heterozygotes and in healthy control individuals. Numbers of subjects are given in parentheses.

From: Chapter 18, Biochemical and genetic diagnosis of Fabry disease

Cover of Fabry Disease
Fabry Disease: Perspectives from 5 Years of FOS.
Mehta A, Beck M, Sunder-Plassmann G, editors.
Oxford: Oxford PharmaGenesis; 2006.
Copyright © 2006, Oxford PharmaGenesis™.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.